CHARLOTTE LANE: Open Payments
NPI 1154868982 · STERLING, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$200 in 11 payments from 6 companies in 2025. Trend: 2023 $514 · 2024 $24 · 2025 $200
Food & beverage: $200
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 3 | $51 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $36 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $21 |
| PFIZER INC. | 1 | $19 |
Products named: JARDIANCE, REPATHA, Kerendia, VERQUVO, CAPVAXIVE, FARXIGA, ELIQUIS, OTEZLA.
Industry payments across VA — which companies pay providers there.
